← Browse by Condition
Medical Condition
systemic sclerosis ssc
Total Trials
7
Recruiting Now
7
Trial Phases
EARLY_Phase 1, Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for systemic sclerosis ssc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — systemic sclerosis ssc Clinical Trials
How many clinical trials are currently recruiting for systemic sclerosis ssc?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for systemic sclerosis ssc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for systemic sclerosis ssc?
systemic sclerosis ssc research spans Phase 1 (2 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a systemic sclerosis ssc clinical trial?
Eligibility criteria for systemic sclerosis ssc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06594302
Recruiting
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Hacettepe University
NCT07402226
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
University of Michigan
NCT07586267 EARLY_Phase 1
Recruiting
Enrollment
15 pts
Location
China
Sponsor
The Children's Hospital of Zhe...
NCT06865118
Recruiting
Enrollment
20 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT06794008 Phase 2
Recruiting
Enrollment
50 pts
Location
China
Sponsor
Peking University People's Hos...
NCT07150000
Recruiting
Enrollment
120 pts
Location
Germany
Sponsor
University of Bonn
NCT07800871 Phase 1, Phase 2
Recruiting
Enrollment
446 pts
Location
United States
Sponsor
Fate Therapeutics
Related Conditions
systemic lupus erthematosus sle (2) rheumatoid arthritis ra (2) anca associated vasculitis aav (2) autoimmune diseases (1) multi drug resistant nephrotic syndrome (1) iga nephropathy igan (1) anca associated systemic vasculitis (1) pulmonary arterial hypertension pah (1) home monitoring follow up (1) systemic lupus erythematosus (1) inflammatory myopathy (1) anca associated vasculitis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology